These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 22910930)

  • 1. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
    Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
    Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
    Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
    Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
    Garcia-Closas M; Hall P; Nevanlinna H; Pooley K; Morrison J; Richesson DA; Bojesen SE; Nordestgaard BG; Axelsson CK; Arias JI; Milne RL; Ribas G; González-Neira A; Benítez J; Zamora P; Brauch H; Justenhoven C; Hamann U; Ko YD; Bruening T; Haas S; Dörk T; Schürmann P; Hillemanns P; Bogdanova N; Bremer M; Karstens JH; Fagerholm R; Aaltonen K; Aittomäki K; von Smitten K; Blomqvist C; Mannermaa A; Uusitupa M; Eskelinen M; Tengström M; Kosma VM; Kataja V; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; ; ; Devilee P; van Asperen CJ; Jacobi CE; Tollenaar RA; Huijts PE; Klijn JG; Chang-Claude J; Kropp S; Slanger T; Flesch-Janys D; Mutschelknauss E; Salazar R; Wang-Gohrke S; Couch F; Goode EL; Olson JE; Vachon C; Fredericksen ZS; Giles GG; Baglietto L; Severi G; Hopper JL; English DR; Southey MC; Haiman CA; Henderson BE; Kolonel LN; Le Marchand L; Stram DO; Hunter DJ; Hankinson SE; Cox DG; Tamimi R; Kraft P; Sherman ME; Chanock SJ; Lissowska J; Brinton LA; Peplonska B; Klijn JG; Hooning MJ; Meijers-Heijboer H; Collee JM; van den Ouweland A; Uitterlinden AG; Liu J; Lin LY; Yuqing L; Humphreys K; Czene K; Cox A; Balasubramanian SP; Cross SS; Reed MW; Blows F; Driver K; Dunning A; Tyrer J; Ponder BA; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gabrieau V; Sigurdson A; Doody M; Struewing JP; Alexander B; Easton DF; Pharoah PD
    PLoS Genet; 2008 Apr; 4(4):e1000054. PubMed ID: 18437204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
    Huijts PE; Vreeswijk MP; Kroeze-Jansema KH; Jacobi CE; Seynaeve C; Krol-Warmerdam EM; Wijers-Koster PM; Blom JC; Pooley KA; Klijn JG; Tollenaar RA; Devilee P; van Asperen CJ
    Breast Cancer Res; 2007; 9(6):R78. PubMed ID: 17997823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
    Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
    Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
    Reeves GK; Travis RC; Green J; Bull D; Tipper S; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
    JAMA; 2010 Jul; 304(4):426-34. PubMed ID: 20664043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.
    Travis RC; Reeves GK; Green J; Bull D; Tipper SJ; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
    Lancet; 2010 Jun; 375(9732):2143-51. PubMed ID: 20605201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
    Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
    J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
    Chen Y; Shi C; Guo Q
    World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
    Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
    Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
    Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
    Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.
    Liang J; Chen P; Hu Z; Shen H; Wang F; Chen L; Li M; Tang J; Wang H; Shen H
    Breast Cancer Res Treat; 2010 Nov; 124(1):237-41. PubMed ID: 20213080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
    Antoniou AC; Sinilnikova OM; McGuffog L; Healey S; Nevanlinna H; Heikkinen T; Simard J; Spurdle AB; Beesley J; Chen X; ; Neuhausen SL; Ding YC; Couch FJ; Wang X; Fredericksen Z; Peterlongo P; Peissel B; Bonanni B; Viel A; Bernard L; Radice P; Szabo CI; Foretova L; Zikan M; Claes K; Greene MH; Mai PL; Rennert G; Lejbkowicz F; Andrulis IL; Ozcelik H; Glendon G; ; Gerdes AM; Thomassen M; Sunde L; Caligo MA; Laitman Y; Kontorovich T; Cohen S; Kaufman B; Dagan E; Baruch RG; Friedman E; Harbst K; Barbany-Bustinza G; Rantala J; Ehrencrona H; Karlsson P; Domchek SM; Nathanson KL; Osorio A; Blanco I; Lasa A; Benítez J; Hamann U; Hogervorst FB; Rookus MA; Collee JM; Devilee P; Ligtenberg MJ; van der Luijt RB; Aalfs CM; Waisfisz Q; Wijnen J; van Roozendaal CE; ; Peock S; Cook M; Frost D; Oliver C; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Cole T; Hodgson S; ; Godwin AK; Stoppa-Lyonnet D; Buecher B; Léoné M; Bressac-de Paillerets B; Remenieras A; Caron O; Lenoir GM; Sevenet N; Longy M; Ferrer SF; Prieur F; ; Goldgar D; Miron A; John EM; Buys SS; Daly MB; Hopper JL; Terry MB; Yassin Y; ; Singer C; Gschwantler-Kaulich D; Staudigl C; Hansen Tv; Barkardottir RB; Kirchhoff T; Pal P; Kosarin K; Offit K; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov EN; Allavena A; Schmutzler RK; Versmold B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Deissler H; Fiebig B; Suttner C; Schönbuchner I; Gadzicki D; Caldes T; de la Hoya M; Pooley KA; Easton DF; Chenevix-Trench G;
    Hum Mol Genet; 2009 Nov; 18(22):4442-56. PubMed ID: 19656774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population.
    Elematore I; Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G; Di Capua GA; Jara L
    Mol Biol Rep; 2014 Jun; 41(6):3715-22. PubMed ID: 24532140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population.
    He Y; Liu H; Chen Q; Sun X; Liu C; Shao Y
    Tumour Biol; 2016 Jul; 37(7):9739-44. PubMed ID: 26803517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
    Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
    Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
    Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
    Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of genetic breast cancer susceptibility variants as prognostic factors.
    Fasching PA; Pharoah PD; Cox A; Nevanlinna H; Bojesen SE; Karn T; Broeks A; van Leeuwen FE; van't Veer LJ; Udo R; Dunning AM; Greco D; Aittomäki K; Blomqvist C; Shah M; Nordestgaard BG; Flyger H; Hopper JL; Southey MC; Apicella C; Garcia-Closas M; Sherman M; Lissowska J; Seynaeve C; Huijts PE; Tollenaar RA; Ziogas A; Ekici AB; Rauh C; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Andrulis IL; Ozcelik H; Mulligan AM; Glendon G; Hall P; Czene K; Liu J; Chang-Claude J; Wang-Gohrke S; Eilber U; Nickels S; Dörk T; Schiekel M; Bremer M; Park-Simon TW; Giles GG; Severi G; Baglietto L; Hooning MJ; Martens JW; Jager A; Kriege M; Lindblom A; Margolin S; Couch FJ; Stevens KN; Olson JE; Kosel M; Cross SS; Balasubramanian SP; Reed MW; Miron A; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Chenevix-Trench G; ; Lambrechts D; Dieudonne AS; Hatse S; van Limbergen E; Benitez J; Milne RL; Zamora MP; Pérez JI; Bonanni B; Peissel B; Loris B; Peterlongo P; Rajaraman P; Schonfeld SJ; Anton-Culver H; Devilee P; Beckmann MW; Slamon DJ; Phillips KA; Figueroa JD; Humphreys MK; Easton DF; Schmidt MK
    Hum Mol Genet; 2012 Sep; 21(17):3926-39. PubMed ID: 22532573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of breast cancer susceptibility loci in Chinese women.
    Long J; Shu XO; Cai Q; Gao YT; Zheng Y; Li G; Li C; Gu K; Wen W; Xiang YB; Lu W; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2357-65. PubMed ID: 20699374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.